Navigation Links
Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW

been associated with mesalamine medications. In patients with renal impairment, caution should be exercised, and LIALDA should be used only if the benefits outweigh the risks. No information is available for patients with hepatic impairment.

LIALDA is generally well tolerated. The majority of adverse events in the double-blind, placebo-controlled trials were mild or moderate in severity. In clinical trials (n=535), the most common treatment-related adverse events with LIALDA 2.4g/day, 4.8g/day and placebo were headache (5.6 percent, 3.4 percent and 0.6 percent, respectively) and flatulence (four percent, 2.8 percent and 2.8 percent, respectively). Pancreatitis occurred in less than one percent of patients during clinical trials and resulted in discontinuation of therapy with LIALDA.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company's website: http://www.shire.com.


    For media inquiries please contact:


    Media            Ashleigh Duchene (GolinHarris)       +1 312 729 4428

                               
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
3. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Haemacure Announces Preliminary Findings of its Plasma Discard Analysis
7. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
10. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease
11. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
Post Your Comments:
(Date:7/1/2015)... , July 1, 2015  Echo Therapeutics, Inc. ... focused on non-invasive continuous glucose monitoring and associated ... and completely re-designed corporate website echotx.com . ... to Echo,s technology and enhances the quality and ... website better communicates to prospective customers and stakeholders ...
(Date:7/1/2015)... and FT LAUDERDALE, Florida , July 1, ... designer, developer, manufacturer and marketer of innovative medical devices for ... 13, 2015, it prevailed in a final opposition appeal hearing ... 1 341 482 - STENT HAVING HELICAL ELEMENTS (,482). The ... the EPO and has been upheld as a valid patent ...
(Date:7/1/2015)... July 1, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of proprietary compounded drug ... The Nasdaq stock market closing bell on Thursday, ... success of its Go Dropless™ campaign since its ... procedures are performed annually in the U.S. and ...
Breaking Medicine Technology:Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... Jan. 31, 2012 The U.S. Food and Drug ... in adult patients following surgical removal of CD117-positive gastrointestinal ... in overall patient survival when the drug is taken ... of treatment. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
... Jan. 31, 2012 Synteract, Inc., a ... its electronic data capture system SynCapture™, providing customers with ... study data to be captured into a single database ... web based, resulting in more seamless, flexible and cost ...
Cached Medicine Technology:FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer 2FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer 3Synteract Releases SynCapture Version 1.5 of Its Hybrid Electronic Data Capture (EDC) System 2
(Date:7/1/2015)... ... July 01, 2015 , ... Convoy of Hope will partner ... Twin Cities on Saturday, August 1, at Spring Lake Park High School. , During ... than $1 million worth of goods and services including free food, health services, family ...
(Date:7/1/2015)... West Orange, NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder ... to the National Scoliosis Foundation, it affects 2 to 3 percent of the population, or ... ages, scoliosis most often develops in children between the ages of 10 and 15. Most ...
(Date:7/1/2015)... ... 2015 , ... A Priority Setting Partnership put in place ... they hope will guide future mesothelioma research. Surviving Mesothelioma has just posted an ... , More than 450 mesothelioma patients, caregivers, and healthcare professionals answer the mesothelioma ...
(Date:7/1/2015)... , ... July 01, 2015 , ... B. E. Smith, ... to lead a national chief nursing officer recruitment for Capital Health ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
(Date:7/1/2015)... CA (PRWEB) , ... July 01, 2015 , ... Research ... Examination Kit (Peek) smartphone app to test eyesight was just as accurate as those ... School of Hygiene and Tropical Medicine is responsible for the development of the test, ...
Breaking Medicine News(10 mins):Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:New Report Identifies Top 10 Mesothelioma Research Priorities, According to Surviving Mesothelioma 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3
... immune systemlead to the "hyperinflammation" characteristic of obesity-related glucose ... from the University of Cincinnati (UC). Cancer ... the cellular mechanisms behind glucose intolerance may provide a ... as well as insights into how aggressive cancers form. ...
... heated, magnetic nanoparticles targeted to cell membranes can ... behavior, according to a paper published by University ... The research could have broad application, potentially resulting ... proteins or cells in specific tissues, or improved ...
... ... Tilda Swinton as the latest famous faces to lend their support to Hear the ... the importance of hearing and the consequences of hearing loss. , , ... (PRWEB) July 6, 2010 -- ...
... LAKE CITY Severe trauma to the head and ... dramatically according to research released today from the University ... be published in the journal Neurosurgery , highlights ... helmet use, and greater efforts to train riders in ...
... ... keys to identifying goals and achieving success during challenging times? How ... and conviction? How does one rebound from the losing things held ... 12 secret keys that inspire readers to overcome feelings of confusion and ...
... ... larger office and more convenient location within the Boise medical community. Still serving ... proximity to one of the major medical centers in Boise. This new office ... to help patients get and stay healthy. , ...
Cached Medicine News:Health News:Fat cells play key role in development of type 2 diabetes 2Health News:With magnetic nanoparticles, scientists remotely control neurons and animal behavior 2Health News:More Big Names Line Up To Support Global Hearing Loss Awareness Initiative 2Health News:More Big Names Line Up To Support Global Hearing Loss Awareness Initiative 3Health News:Head and spine trauma from ATV accidents cost $3.24 billion annually 2Health News:Head and spine trauma from ATV accidents cost $3.24 billion annually 3Health News:New Book, "Driven by Destiny" by Dr. LaVerne Adams, Foreword by Rick Warren Reveals 12 Secret Keys to Transform the Future 2Health News:New Book, "Driven by Destiny" by Dr. LaVerne Adams, Foreword by Rick Warren Reveals 12 Secret Keys to Transform the Future 3Health News:Boise Acupuncture Clinic Grows into Larger Office 2
... switch which allows user to stop rotor before ... with stainless steel pin is virtually indestructible. Lid ... 6 microcentrifuge tubes at low to medium speed ... 6 inch x 6 inch footprint. Starts and ...
Inquire...
Inquire...
... meets or exceeds all the requirements set ... the Determination of Packed Cell Volume by ... U.S. and international standards and protocols., For ... 3411 or 3412 and you'll receive all ...
Medicine Products: